Roweepra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is Levetiracetam.
| Product ID | 69102-108_68f61297-c3f6-4adf-b2b1-edfeb5b006c0 | 
| NDC | 69102-108 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Roweepra | 
| Generic Name | Levetiracetam | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2020-10-28 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA078858 | 
| Labeler Name | OWP Pharmaceuticals, Inc. | 
| Substance Name | LEVETIRACETAM | 
| Active Ingredient Strength | 250 mg/1 | 
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2020-10-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 69102-102 | ROWEEPRA | ROWEEPRA | 
| 69102-104 | ROWEEPRA | ROWEEPRA | 
| 69102-103 | ROWEEPRA | ROWEEPRA | 
| 69102-101 | ROWEEPRA | ROWEEPRA | 
| 69102-108 | Roweepra | Roweepra | 
| 0054-0224 | Levetiracetam | Levetiracetam | 
| 0121-0799 | Levetiracetam | LEVETIRACETAM | 
| 0121-1598 | Levetiracetam | LEVETIRACETAM | 
| 0121-2397 | Levetiracetam | LEVETIRACETAM | 
| 0121-4799 | Levetiracetam | LEVETIRACETAM | 
| 0121-4802 | LEVETIRACETAM | LEVETIRACETAM | 
| 0143-9574 | Levetiracetam | Levetiracetam | 
| 0143-9673 | Levetiracetam | Levetiracetam | 
| 0228-2167 | Levetiracetam | Levetiracetam | 
| 0378-5613 | Levetiracetam | levetiracetam | 
| 0378-5615 | Levetiracetam | levetiracetam | 
| 0378-5617 | Levetiracetam | levetiracetam | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() ROWEEPRA  86634147  5209905 Live/Registered  | 
        OWP Pharmaceuticals, Inc.  2015-05-19  |